Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

19 results
Display

High-dose Sulbactam Treatment for Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter Baumannii

Jeong IB, Na MJ, Son JW, Jo DY, Kwon SJ

BACKGROUND: Several antibiotics can be used to treat ventilator-associated pneumonia caused by carbapenem-resistant A. baumannii (CRAB-VAP) including high-dose sulbactam. However, the effectiveness of high-dose sulbactam therapy is not well known....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of cefotiam-contact anaphylaxis

Lee KH, Choi IS, Lee WJ, Kang SJ, Jeong HK

  • KMID: 2081693
  • Korean J Med.
  • 2009 Apr;76(Suppl 1):S238-S242.
Anaphylaxis caused by beta-lactam antibiotics usually develops following the systemic administration of the drug, although it can also occur with trivial contact of the drug on the skin in extraordinarily...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Immune Hemolytic Anemia Induced by Ceftizoxime and Cefobactam (Sulbactam/Cefoperazone)

Baek EJ, Lee S, Kim S, Choi HK, Kim HO

Simultaneous drug-induced immune hemolytic anemia (DIIHA) caused by multiple drugs is rare. We report a case of a patient who developed DIIHA caused by 2 drugs. The patient's serum exhibited...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Efficacy of Cefoperazone/Sulbactam and Imipenem/Cilastatin for Treatment of Acinetobacter Bacteremia

Choi JY, Kim CO, Park YS, Yoon HJ, Shin SY, Kim YK, Kim MS, Kim YA, Song YG, Yong D, Lee K, Kim JM

Multiple antibiotic reisistance threatens successful treatment of Acinetobacter baumannii infections worldwide. Increasing interest in the well-known activity of sulbactam against the genus Acinetobacter has been aroused. The purpose of this...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients

Ozyilkan O, Yalcintas , Baskan S

  • KMID: 760329
  • Korean J Intern Med.
  • 1999 Jul;14(2):15-19.
The treatment of infectious complications in cancer patients has evolved as a consequence of the developments in the chemotherapy of cancer patients. In this prospective, randomized study, we...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
In Vitro Activities of Ceftriaxone-Sulbactam against Major Aerobic and Anaerobic Bacteria from Clinical Samples

Cho S, Chung HS, Lee Y, Kim M, Yong D, Jeong SH, Lee K, Chong Y

BACKGROUND: beta-lactam antibiotics are one of the most common antimicrobial agents. However, the increasing of beta-lactamase-producing bacteria makes these agents less useful. Therefore, agents stable for beta-lactamase have been developed....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Infectious Spondylodiscitis due to Parvimonas Micra

Kang YM, Kim G, Jung YH, Kim CH, Kim EC, Kim NJ, Oh MD

  • KMID: 2263567
  • Korean J Med.
  • 2012 May;82(5):632-636.
Parvimonas micra is frequently associated with periodontal disease as well as respiratory, gastrointestinal, and female genitourinary tract infections, but only rarely has it been reported as a pathogenic agent of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
First Report of Nocardia farcinica Bursitis in a Patient with Diabetes Mellitus

Park SD, Kim HJ, Jang IH, Uh Y, Kim J, Yoon KJ, Oh JR

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Study for the Efficacy and Safety of Piperacillin/sulbactam (Combicin(R)) in the Treatment of Urinary Tract Infection (Phase III)

Lee KS, Chang KH, Kim YK, Kim MS, Choi JY, Kim CO, Huh AJ, Yeom JS, Chung DR, Chung JW, Woo JH, Kim JM

  • KMID: 2082958
  • Korean J Infect Dis.
  • 2002 Aug;34(4):235-241.
BACKGROUND: Combicin(R) is a new product of beta- lactam and beta-lactamase inhibitor combination which has antibacterial activity against aerobic and anaerobic bacteria, comprised of piperacillin and sulbactam. A phase III...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A randomized, phase II, dose-ranging trial of metampicillin/sulbactam (Mepicin) in the treatment of acute pyelonephritis

Sohn JW, Kim CH, Park O, Cheong HJ, Kim WJ, Kim MJ, Park SC, Kim SI, Kim YK

  • KMID: 2147923
  • Korean J Infect Dis.
  • 2000 Apr;32(2):135-140.
Background: Mepicin is new product comprised of metampicillin; broad spectrum penicillin and sulbactam; beta-lactamase inhibitor. The purpose of this study was to determine the efficacy, safety, and appropriate dosage of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The First Korean Case of Moraxella osloensis Bacteremia in a Patient with Acute Myeloid Leukemia

Sung JY, Hong SK, Kim EC

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Study of Pharyngeal Gonorrhea

Choi KH, Kim JH, Kim JH

  • KMID: 1679265
  • Korean J Dermatol.
  • 1985 Jun;23(3):331-339.
Five hundred seventeen male patients with gonococcal urethritis at the VD clinic of Chocng-ku Public Health Center between Feb. 27 and Oct. 27, 1984 the were source cf this study....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Comparative Study of Community-acquired Klebsiella pneumoniae Bacteremia and Escherichia coli Bacteremia

Choi YH, Lee SM, Park KJ, Hwang SC, Lee YH, Hahn MH

  • KMID: 2248702
  • Korean J Infect Dis.
  • 2000 Jun;32(3):197-202.
BACKGROUND: Klebsiella pneumoniae is the second most common causative pathogen only next to Escherichia coli among the facultative Gram-negative rods causing both community-acquired and nosocomial bacteremia. METHODS: We have reviewed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
16S Ribosomal RNA Identification of Prevotella nigrescens from a Case of Cellulitis

Yang JJ, Kwon TY, Seo MJ, Nam YS, Han CS, Lee HJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Features of Group B β-hemolytic Streptococcal Infection in Infants and Children

Kim YK, Kwak YH, Kim YJ, Jung HS, Hong JY, Lee HJ

BACKGROUND: Group B β-hemolytic Streptococcus(GBS) has been the major pathogen of neonatal sepsis in western country. In contrast, GBS has played little role in neonatal sepsis in Korea. But recently,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
First Isolation of Streptococcus gallolyticus subsp. pasteurianus from a Korean Patient with Severe Septic Shock

Jeong S, Park JY, Han SH, Lee Y, Yong D, Lee K, Chong Y

A 60-year-old man presented with a 1-day history of fever, vomiting, and diarrhea. He was diagnosed with severe septic shock on the basis of a body temperature of 38.9degrees C,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Synergy of Arbekacin-based Combinations Against Vancomycin Hetero-intermediate Staphylococcus aureus

Lee JY, Oh WS, Ko KS, Heo ST, Moon CS, Ki HK, Kiem S, Peck KR, Song JH

This study was undertaken to evaluate the in vitro activities of arbekacin-based combination regimens against vancomycin hetero-intermediate Staphylococcus aureus (hetero-VISA). Combinations of arbekacin with vancomycin, rifampin, ampicillin-sulbactam, teicoplanin, or quinipristin-dalfopristin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Distribution of Genomic Species and Antimicrobial Susceptibility in Acinetobacters Isolated from Gangjin Bay, Korea

Oh JY, Jeong YW, Joo HS, Chong WS, Lee JC, Tamang MD, Lee WB, Park JC

A total of 90 Acinetobacter isolates from freshwater and seawater in Gangjin Bay of Korea was investigated for the distribution of genomic species, antimicrobial resistance patterns and clonal relatedness. By...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Liver Abscess Caused by Fusobacterium nucleatum in a Patient with Recurrent Periodontal Diseases

Kim YH, Yoon HJ, Park CW, Kim JH, Lee MK, Kim KB, Na DJ, Kim JM

Fusobacteria are anaerobic gram-negative, non-spore forming bacilli found in normal flora of the oral cavity, urogenital tract, and gastrointestinal tract. Fusobacterium nucleatum has been seldom reported as a cause of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr